HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

How many sets of 4DCT images are sufficient to determine internal target volume for liver radiotherapy?

AbstractBACKGROUND AND PURPOSE:
To determine the feasibility of using limited four-dimensional computed tomography (4DCT) images for treatment planning.
MATERIALS AND METHODS:
The 4DCT scans of 16 patients with hepatocellular carcinoma (HCC) were analyzed. Gross tumor volumes (GTVs) were manually contoured on all 10 respiratory phases, and different internal clinical target volumes (ICTVs) were derived by encompassing volumes of the respective CTVs. Volume, position, and shape of ICTVs were calculated and compared.
RESULTS:
The ICTV(2 phases), ICTV(3 phases), ICTV(4 phases), and ICTV(6 phases) all showed excellent agreement with ICTV(10 phases), and the ICTV(2 phases) encompassed ICTV(10 phases) by 94.1+/-1.8% on average. The 3D shift between the centers of mass of the ICTVs was only 0.6mm. The surface distance between ICTV(10 phases) and ICTV(2 phases) was 1.7+/-0.8mm in the left-right (LR) and anteroposterior (AP) directions.
CONCLUSIONS:
Contouring two extreme phases at end-inhalation and end-exhalation is a reasonably safe and labor-saving method of deriving ITV for liver radiotherapy with low and medium tumor motion amplitude (1.6 cm). Whether the larger tumor movement affects the results is the subject of ongoing research.
AuthorsMian Xi, Meng-Zhong Liu, Li Zhang, Qiao-Qiao Li, Xiao-Yan Huang, Hui Liu, Yong-Hong Hu
JournalRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (Radiother Oncol) Vol. 92 Issue 2 Pg. 255-9 (Aug 2009) ISSN: 1879-0887 [Electronic] Ireland
PMID19520447 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Carcinoma, Hepatocellular (diagnostic imaging, pathology, radiotherapy)
  • Female
  • Humans
  • Liver Neoplasms (diagnostic imaging, pathology, radiotherapy)
  • Male
  • Middle Aged
  • Tomography, X-Ray Computed (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: